Columbia University Medical Center   discover care educate lead hdsa center of excellence    
at the NY state psychiatric institute

If you notice any problems with the website, please email site editor.


Journal Articles, Books, and Book Chapters

  1. Andresen JM. Gayan J. Djousse L. Roberts S. Brocklebank D. Cherny SS. The US-Venezuela Collaborative Research Group. The HD MAPS Collaborative Research Group. Cardon LR. Gusella JF. Macdonald ME. Myers RH. Housman DE. Wexler NS. The Relationship Between CAG Repeat Length and Age of Onset Differs for Huntington's Disease Patients with Juvenile Onset or Adult Onset. Annals of Human Genetics. 71(Pt 3):295-301, 2007 May.
  2. Anderson KE. Marder KS.  An overview of psychiatric symptoms in Huntington's disease. Current Psychiatry Reports. 3(5):379-88, 2001 Oct.
  3. Anderson KE. Louis ED. Stern Y. Marder KS. Cognitive correlates of obsessive and compulsive symptoms in Huntington's disease.  American Journal of Psychiatry. 158(5):799-801, 2001 May.
  4. Anderson K, Marder K . Huntington's Disease in: Johnson RT, Griffin J, McArthur JC (ed) Current Therapy in Neurologic Disease, 6th ed., Mosby, St Louis, 2002, 282-286.
  5. Anderson KE, Marder KS. Huntington’s Disease. Current Clnical Neurology: Psychiatry for Neurologists. DV Jeste and JH Friedman (eds) 2005 Human Press. Totowa NJ. (CARE-HD)
  6. Chatterjee A., Marder  K. Basal Ganglia disease and Depression. In "Late Life Depression" Eds Roose SP, Sackeim HA. pp348-360. Oxford University Press, New York, 2004
  7. Chatterjee A, Anderson KE, Moskowitz, CB, Hauser WA, Marder, KS: A Comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington’s Disease.  Journal of Neuropsychiarty and Clinical Neuroscience, Summer 2005; 17:3
  8. Djousse L. Knowlton B. Cupples LA. Marder K. Shoulson I. Myers RH, for the investigators of the Huntington Study Group.  Weight loss in early stage of Huntington's disease. Neurology. 59(9):1325-30, 2002 Nov 12.  (CARE-HD)
  9. Frucht SJ, Fahn S, eds. Movement Disorder Emergencies: diagnosis and treatment. Humana Press. New Jersey. 2005
  10. Gaba A, Zhang K, Marder K, Moskowitz C, Werner P, Boozer CN. Energy balance in early-stage Huntington’s disease.  American Journal of Clinical Nutrition.  Vol 81, No.6, 1335-1341, June 2005. (DIET)
  11. Gaba, A.  Micronutrient Intakes of People with Early-Stage Huntington Disease. Journal of the American Dietetic Association.  Vol 106, Issue 8, Supp. 1, page A15, Aug. 2006
  12. Gaba, Ann.  Nutrition and Huntington’s Disease: A Guide for Families, HDSA 1997.  Available through HDSA.
  13. Gomez-Tortosa E. MacDonald ME. Friend JC. Taylor SA. Weiler LJ. Cupples LA. Srinidhi J. Gusella JF. Bird ED. Vonsattel JP. Myers RH. Quantitative neuropathological changes in presymptomatic Huntington's disease.  Annals of Neurology. 49 (1):29-34, 2001 Jan.
  14. Gordon AM. Quinn L. Reilmann R. Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Experimental Neurology. 163(1):136-48, 2000 May.  doi:10.1006/exnr.2000.7348 
  15. Groves M. Vonsattel JP. Mazzoni P. Marder K. Huntington's disease. Science of Aging Knowledge Environment. 2003(43):dn3, 2003 Oct 29;2003/43/dn3
  16. Hersch SM. Gevorkian S. Marder K. Moskowitz C. Feigin A. Cox M. Como P. Zimmerman C. Lin M. Zhang L. Ulug AM. Beal MF. Matson W. Bogdanov M. Ebbel E. Zaleta A. Kaneko Y. Jenkins B. Hevelone N. Zhang H. Yu H. Schoenfeld D. Ferrante R. Rosas HD. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology. 66(2):250-2, 2006 Jan 24.
  17. Hogarth P, Kayson E, Kieburz K, Marder K, Oakes K, Rosas D, Shoulson I, Wexler N, Young AB, Zhao H, the US Venezuela HD Collaborative Research Group, the Huntington Study Group. Interrater agreement in the assessment of motor manifestations of Huntington’s Disease. Mov Disord 2005;20:293-297
  18. Jacobs DM, Levy G, Marder K. Dementia in Parkinson's disease, Huntington's disease and related disorders. Behavioral Neurology and Neuropsychology (2 nd Edition) Feinberg T and Farah M (eds) McGraw Hill 2003;593-607
  19. Klitzman, R. Thorne, D. Williamson, J. Chung, W. Marder, K.  Disclosures of Huntington disease risk within families: Patterns of decision-making and implications.  Am J Med Genet A.  2007 Aug 15; 143(16): 1835-49
  20. Klitzman, R., Thorne, D. Williamson, J. Marder, K.  The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington disease.  Genet Med. 2007 Jun; 9(6) 358-71
  21. Klitzman, R., Thorne., D. Williamson, J., Chung, W. Marder, K.  Decision-Making About Reproductive Choices Among Individuals At-Risk for Huntington’s Disease.  J Genet Couns. 2007 Jun; 16(3): 347-62
  22. Li JL. Hayden MR. Warby SC. Durr A. Morrison PJ. Nance M. Ross CA. Margolis RL. Rosenblatt A. Squitieri F. Frati L. Gomez-Tortosa E. Garcia CA. Suchowersky O. Klimek ML. Trent RJ. McCusker E. Novelletto A. Frontali M. Paulsen JS. Jones R. Ashizawa T. Lazzarini A. Wheeler VC. Prakash R. Xu G. Djousse L. Mysore JS. Gillis T. Hakky M. Cupples LA. Saint-Hilaire MH. Cha JH. Hersch SM. Penney JB. Harrison MB. Perlman SL. Zanko A. Abramson RK. Lechich AJ. Duckett A. Marder K. Conneally PM. Gusella JF. MacDonald ME. Myers RH. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.  BMC Medical Genetics. 7:71, 2006.
  23. Louis ED. Lee P. Quinn L. Marder K. Dystonia in Huntington's disease: prevalence and clinical characteristics. Movement Disorders. 14(1):95-101, 1999 Jan.
  24. Louis ED. Marder K. Moskowitz C. Greene P. Arm elevation in Huntington's disease: dystonia or levitation?. Movement Disorders. 14(6):1035-8, 1999 Nov.
  25. Louis ED. Anderson KE. Moskowitz C. Thorne DZ. Marder K. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Archives of Neurology. 57(9):1326-30, 2000 Sep.
  26. Louis ED, Tampone E. Bruxism in Huntington's disease (Letter). Mov Disord 2001;16:785.
  27. Marder K. Zhao H. Myers RH. Cudkowicz M. Kayson E. Kieburtz K. Orme C. Paulsen J. Penney JB Jr. Siemers E. Shoulson I. Rate of functional decline in Huntington's disease. Huntington Study Group.  Neurology. 54(2):452-8, 2000 Jan 25
  28. Marder K. Sandler S. Lechich A. Klager J. Albert SM. Relationship between CAG repeat length and late-stage outcomes in Huntington's disease. Neurology. 59(10):1622-4, 2002 Nov 26.
  29. Moskowitz CB. Marder K. Palliative care for people with late-stage Huntington's disease. Neurologic Clinics. 19(4):849-65, 2001 Nov.
  30. Quinn L. Reilmann R. Marder K. Gordon AM. Altered movement trajectories and force control during object transport in Huntington's disease. Movement Disorders. 16(3):469-80, 2001 May.
  31. Quinn L and Rao A . Physical therapy in Huntington's disease: current perspectives and case report. Neurology Report, 2002; 26(3), 145-153.
  32. Quinn L and Gordon J (2003). Functional outcomes documentation in rehabilitation. W.B. Saunders: Philadelphia.
  33. Quinn L. Co-editor of special topics issues of Neurology Report on Degenerative Diseases, October 2002.
  34. Rao, A.K., Quinn, L and Marder, K. Reliability of spatio-temporal gait outcome measures in Huntington's Disease. Mov. Disord. 2005; 20 (8):1033-1037.
  35. Reilmann R. Kirsten F. Quinn L. Henningsen H. Marder K. Gordon AM. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology. 57(5):920-4, 2001 Sep 11.
  36. Sano M, Marder K, and Dooneief G. Basal Ganglia Disorders. In: Fogel, Schiffer R and Rao S (eds). Neuropsychiatry. Baltimore , MD : Williams & Wilkins 1996, 805-825. Marder K. Huntington's Disease.
  37. Sevigny JJ, Chin SS, Milewski Y, Albers MW, Gordon ML, Marder K. HIV encephalitis simulating Huntington’s disease. Mov Disord 2005; PMID:15704206
  38. Tanner CM and Marder K. Movement Disorders. In: Neuroepidemiology: From Principles to Practice. Nelson LM, Tanner CM, Van Den Eeden SK, McGuire VM (eds) Oxford University Press 2004; 131-161.
  39. Wheelock VL. Tempkin T. Marder K. Nance M. Myers RH. Zhao H. Kayson E. Orme C. Shoulson I. Huntington Study Group. Predictors of nursing home placement in Huntington disease. Neurology. 60(6):998-1001, 2003 Mar 25.
  40. Wexler NS. Lorimer J. Porter J. Gomez F. Moskowitz C. Shackell E. Marder K. Penchaszadeh G. Roberts SA. Gayan J. Brocklebank D. Cherny SS. Cardon LR. Gray J. Dlouhy SR. Wiktorski S. Hodes ME. Conneally PM. Penney JB. Gusella J. Cha JH. Irizarry M. Rosas D. Hersch S. Hollingsworth Z. MacDonald M. Young AB. Andresen JM. Housman DE. De Young MM. Bonilla E. Stillings T. Negrette A. Snodgrass SR. Martinez-Jaurrieta MD. Ramos-Arroyo MA. Bickham J. Ramos JS. Marshall F. Shoulson I. Rey GJ. Feigin A. Arnheim N. Acevedo-Cruz A. Acosta L. Alvir J. Fischbeck K. Thompson LM. Young A. Dure L. O'Brien CJ. Paulsen J. Brickman A. Krch D. Peery S. Hogarth P. Higgins DS Jr. Landwehrmeyer B. U.S.-Venezuela Collaborative Research Project. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proceedings of the National Academy of Sciences of the United States of America. 101(10):3498-503, 2004 Mar 9.

Copyright 2000-2009 HDNY.ORG : At NY State Psychiatric Institute
Columbia University Medical Center : Department of Neurology : Last updated 27-Jun-2009